Key facts
- Scentian Bio’s last known valuation is $7.0M (Sep 2023).
- It has raised $10.9M; the latest was Later Stage VC ($7.0M) in Apr 2026.
- Notable investors include OurCrowd, Gates Foundation, Icehouse Ventures, Toyota Ventures, K1W1 — 17 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 17 names
- ·Watchlist + deal alerts for Scentian Bio
- ·The full record, as it builds
Funding rounds
No funding rounds for Scentian Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Scentian Bio
Developer of biosensor devices designed to detect and interpret chemical signals using insect biology and nanotechnology. The company offers sensors based on insect odorant receptors combined with machine learning for analyzing volatile organic compounds in food and medical applications, enabling industries to identify quality issues, detect adulteration, and gain real-time chemical insights.
- Sector
- Information Technology
- HQ
- Auckland, New Zealand
- Founded
- 2020
- Employees
- 7
- Website
- scentianbio.com/
- Ownership
- Privately Held (backing)
Scentian Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Scentian Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Scentian Bio in its N-PORT filings yet. We sweep new filings monthly.